Logo InMode Ltd. - INMD 14.76 USD

P/E
8.59
EPS
2.11
P/B
1.88
ROE
25.54
Beta
2.19
Target Price
21.20 USD

14.760 USD

14.760 USD

Daily: +1.58%
Key Metrics

Earnings date: April 27, 2025

P/E: 8.59

EPS: 2.11

Book Value: 9.65

Price to Book: 1.88

Debt/Equity: 0.76

% Insiders: 9.693%

Growth

Revenue Growth: -0.24%

Earnings Growth: -0.40%

Estimates

Forward P/E: 8.27

Forward EPS: 2.19

Target Mean Price: 21.20

 Logo About InMode Ltd. - (INMD)

Country: Israel

Sector: Health Care

Website: http://www.inmodemd.com

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Exchange Ticker
NMS (United States) INMD

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Oct. 1, 2021 2.00
Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion